Showing 4051-4060 of 4062 results for "".
- Omeros Announces Upcoming Presentations of New Data on Omidria at the ASCRS Meetinghttps://modernod.com/news/omeros-announces-upcoming-presentations-of-new-data-on-omidria-at-the-ascrs-meeting/2480246/Omeros announced that the results of four studies directed to the benefits of Omidria across a range of clinical situations in cataract surgery will be presented at the upcoming American Society of Cataract and Refractive Surgery (ASCRS) Congress in Washington, D.C., April 13-17, 2018. The
- New Data from the HORIZON Trial of the Hydrus Microstent Shows Lower IOP and Medication Usehttps://modernod.com/news/new-data-from-the-horizon-trial-of-the-hydrus-microstent-shows-lower-iop-and-medication-use/2480249/Ivantis announced that the HORIZON US cohort data will be presented at the annual meeting of the American Society of Cataract and Refractive Surgery (ASCRS) in Washington DC on Saturday, April 14, 2018. The full global HORIZON pivotal
- EyePoint Pharmaceuticals Strengthens Global IP With Notices of Allowance for Two U.S. Patents Related to Dexycuhttps://modernod.com/news/eyepoint-pharmaceuticals-strengthens-global-ip-with-notices-of-allowance-for-two-u-s-patents-related-to-dexycu/2480252/EyePoint Pharmaceuticals announced that the U.S. Patent and Trademark Office (USPTO) has issued Notices of Allowance for two patents covering Dexycu, the company’s FDA-approved long-acting intraocular product for the treatment of postoperative inflammation. The first patent (U.S. patent ap
- Ellex’s Patented Glaucoma Treatment Technologies to be Spotlighted at ASCRShttps://modernod.com/news/ellexs-patented-glaucoma-treatment-technologies-to-be-spotlighted-at-ascrs/2480253/Ellex Medical Lasers Limited announced that it will showcase its proprietary glaucoma treatment portfolio, including its breakthrough iTrack minimally invasive glaucoma surgery (MIGS) technology, at the 2018 annual meeting of the American Society of Cataract and Refractive Surgery (ASCRS) in Wash
- Alcon to Present Robust Clinical Program, New Innovations at ASCRShttps://modernod.com/news/alcon-to-present-robust-clinical-program-new-innovations-at-ascrs/2480259/Alcon will showcase advancements in the cataract, glaucoma, and refractive spaces during the American Society of Cataract and Refractive Surgery (ASCRS) 2018 annual meeting, taking place April 13-17 in Washington, D.C. The company will leverage nearly 90 scientific abstract presentations, several
- Rayner Launches 600C Monofocal Aspheric IOL in US at ASCRShttps://modernod.com/news/rayner-set-to-launch-600c-monofocal-aspheric-iol-in-us-at-ascrs/2480265/Rayner has announced the US launch of the 600C Aspheric IOL, which will be unveiled at the upcoming 2018 ASCRS conference in Washington DC, April 13-17. The product will be available following the conference. Built on the
- Imprimis to Feature its Cyclosporine/Chondroitin Sulfate and Non-Opioid MKO Melt Formulations at the Upcoming ASCRS Meetinghttps://modernod.com/news/imprimis-to-feature-its-cyclosporine-chondroitin-sulfate-and-non-opioid-mko-melt-formulations-at-the-upcoming-ascrs-meeting/2480266/Imprimis Pharmaceuticals and its ophthalmology-focused ImprimisRx division announced its participation and related physician presentations at the 2018 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting to be held at the Walter E. Washington Convention Center in Washington,
- Market Scope: Patient Demand for Better Vision Will Drive Double-Digit Growth in IOL Revenueshttps://modernod.com/news/patient-demand-for-better-vision-will-drive-double-digit-growth-in-iol-revenues/2480268/Technological innovations in premium IOLs will help drive global IOL revenues to more than $6.1 billion by 2023, according to Market Scope data.
- FCLSA, FSLS, FBCLAhttps://modernod.com/profiles/fclsa-fsls-fbcla/j1e8xv/
- Christina Y. Weng, MD, MBA, FASRShttps://modernod.com/profiles/christina-y-weng-md-mba-fasrs/LkEPMo/Christina Y. Weng, MD, MBA is Professor of Ophthalmology and the Vitreoretinal Diseases & Surgery Fellowship Program Director at the Baylor College of Medicine in Houston, Texas. She has a faculty appointment at the Level 1 trauma center, Ben Taub General Hospital. Dr. Weng was a prior recipient of…